A placebo-controlled randomized-trial marked by limited enrollment and early trial termination shows that inhaled cyclosporine, when added to systemic immune suppression for lung transplant recipients, was safe and improved early-in-trial clinical parameters of bronchiolitis obliterans syndrome. See Kneidinger et al. (page 222).

中文翻译：

---

利用肺移植受者吸入局部免疫抑制的概念

一项以有限入组和提前终止为标志的安慰剂对照随机试验表明，吸入环孢菌素在肺移植受者的全身免疫抑制中使用时是安全的，并且改善了闭塞性细支气管炎综合征的早期试验临床参数。参见 Kneidinger 等人。（第 222 页）。